Tuesday, January 14, 2014 12:58:41 PM
It's been a while since I added my 2 cents to the conjecture and speculation. I have been invested CTIX for 2 years now and still hold a average cost of under a buck. I've seen these conferences come and go and each one has been preceded by a strong run up followed by a pull back. I don't see the same activity prior to this conference. Perhaps it's due to the rather significant drop in SP we sustained in the past several weeks and our current SP actually represents a slow run up. If that is the case I would anticipate buying opportunities to emerge Thursday and Friday.
I don't feel that Leo has used these conferences as a platform for major announcements in the past and I have yet to see one spark a major sustained increase in SP. They do give investors a focal point for our speculation but I don't have high expectations. I continue to await the test that will hopefully reveal signs of p53 activation via p21. We have been told this information is just around the corner for nearly a year now and the last results were encouraging but inconclusive. Leo barely mentioned them in his last presentation and was extremely cautious with his phrasing.
Now, the company has brought new drugs into the pipeline and updated us very little on K and we've seen what can be called a delay in P. The investment in B has not yet been reflected in shareholder value and has failed to keep us above the $2 mark for uplisting. I may be in the minority but I believe holding an SP above $2 was a strong motivating factor in the investment. In fact, since the acquisition we have seen a more volatile stock and a huge pull back. I believe this is due to general uncertainty about the company's ability to finance a whole new pipeline, lack of news from the K trials and confusion about the investment in B.
I am overall very positive about CTIX and ultimately I think there is value in this company but I have grown tired of thinking that every conference is the ignition point. I look for the next real catalyst to be a progression of K or P mid 2014. Then, of course, there is always the little twinge that tomorrow could be a huge day.
Good Luck to All and may Patience be with you!
I don't feel that Leo has used these conferences as a platform for major announcements in the past and I have yet to see one spark a major sustained increase in SP. They do give investors a focal point for our speculation but I don't have high expectations. I continue to await the test that will hopefully reveal signs of p53 activation via p21. We have been told this information is just around the corner for nearly a year now and the last results were encouraging but inconclusive. Leo barely mentioned them in his last presentation and was extremely cautious with his phrasing.
Now, the company has brought new drugs into the pipeline and updated us very little on K and we've seen what can be called a delay in P. The investment in B has not yet been reflected in shareholder value and has failed to keep us above the $2 mark for uplisting. I may be in the minority but I believe holding an SP above $2 was a strong motivating factor in the investment. In fact, since the acquisition we have seen a more volatile stock and a huge pull back. I believe this is due to general uncertainty about the company's ability to finance a whole new pipeline, lack of news from the K trials and confusion about the investment in B.
I am overall very positive about CTIX and ultimately I think there is value in this company but I have grown tired of thinking that every conference is the ignition point. I look for the next real catalyst to be a progression of K or P mid 2014. Then, of course, there is always the little twinge that tomorrow could be a huge day.
Good Luck to All and may Patience be with you!
